News

Publication in BMJ marks Sacha Stomlund’s successful completion of her ReproUnion funded PhD

Aug 12, 2020

On the 6th of August, the British Medical Journal (BMJ) published the article “Freeze-all versus fresh blastocyst transfer strategy during IVF”, which is based on the ReproUnion supported PhD project, which Sacha Stormlund successfully defended in June.

A key objective was to compare “freeze-all embryos” with conventional fresh embryo transfer and 460 women from Denmark, Sweden and Spain participated in the multicentre, randomised controlled trial.

“The ambition of the study was to increase pregnancy rates and decrease the risk of ovarian hyperstimulation syndrome (OHSS), which is the main side-effect associated with IVF treatment,” says Professor Anja Pinborg, Rigshospitalet, who was the principal supervisor on the PhD project.

The findings in the PhD project indicated similar ongoing pregnancy rates after frozen compared to fresh embryo transfer. Sacha Stormlund concluded that fresh embryo transfer is safe and efficient, if there is no risk of OHSS.

“Thanks to the study we can now with peace of mind put the fresh egg back during the stimulated cycle. But when it comes to woman who are at risk of OHSS, we also know that freezing of all the embryos is the right strategy – with no impact on their chance to become pregnant,” explains Anja Pinborg.

Sacha Stormlund also assessed the women’s attitudes towards a ‘freeze-all’ strategy through a questionnaire, which found that they were overall positive towards freeze-all if the chance of pregnancy was the same.

“I am very pleased that I had the opportunity to complement my clinical study with a patient questionnaire to understand how patients perceive the choice between freeze-all and fresh embryo transfer. Overall, we can say that that the health of the mother and their baby remains of highest importance both from a clinical and the patients’ perspective and most importantly most couples can avoid the extra waiting time to pregnancy related to the freeze-all strategy,” reflects Sacha about her PhD studies.

Find out more about the ReproUnion funded PhD here and its conclusion, published in the BMJ article.

MORE NEWS


ReproUnion Researchers at the BII Summerschool!

This week, 5 of our brilliant ReproUnion researchers— Angel Elenkov, Ann Holm Hansen & Lærke Priskorn focusing on male infertility and Hannah Schorle & Judith Bello Rodríguez focusing on female infertility - are diving deep into the BII Summerschool:...

read more

Engage with ReproUnion at Folkemødet

Come join us to learn more about how ReproUnion aim at patient centered care for infertile patients through the establishment of an Innovation platform and projects run in close collaboration between academia, public hospitals, industry and incubators. ReproUnion...

read more

It’s a couple issue!

At the Women's health network meeting: "Driving innovation and empowerment to improve women´s health", arranged by Hologic, Inc. and Medicon Valley Alliance, Lærke Priskorn, Researcher at Department of Growth and Reproduction, Rigshospitalet was one of four Nordic...

read more